Literature DB >> 8172889

Roles of disulfide bonds in recombinant human interleukin 6 conformation.

F L Rock1, X Li, P Chong, N Ida, M Klein.   

Abstract

Human IL-6 has two disulfide bonds linking Cys45 to Cys51 and Cys74 to Cys84, respectively. Previous site-directed mutagenesis studies have demonstrated that the Cys74-Cys84 bond is essential for full biological and receptor binding activities. To address the structural importance of these disulfide bonds in the formation and stabilization of IL-6 secondary and tertiary structures, we have generated a panel of disulfide bond-deficient rIL-6 analogs both by chemical reduction and alkylation as well as by site-directed mutagenesis. Conformational changes affecting these rIL-6 analogs were probed by circular dichroism spectroscopy, as well as reactivity with monoclonal antibodies, and correlated with changes in biological activities. We have shown that the first disulfide bridge (Cys45-Cys51) is highly sensitive to reduction and, therefore, more solvent-exposed or less thermodynamically stable. Contrary to previous reports, this bridge contributes, although minimally, to the full biological activity of the cytokine. However, no significant changes in secondary or tertiary structures were observed upon removal of this bond. In marked contrast, analogs lacking the disulfide bridge between Cys74 and Cys84 exhibited as little as 0.5% and 0.05% wild-type biological and receptor binding activities, respectively. These dramatic changes correlated with a slight reduction in alpha-helical content and a decreased reactivity with the neutralizing monoclonal antibody mAb8 which recognizes a conformational epitope associated with the active site. Our results suggest that the second disulfide bridge plays a critical role in maintaining the spatial relationship between the putative IL-6 A and D helices.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172889     DOI: 10.1021/bi00183a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Rapid mRNA-display selection of an IL-6 inhibitor using continuous-flow magnetic separation.

Authors:  C Anders Olson; Jonathan D Adams; Terry T Takahashi; Hangfei Qi; Shannon M Howell; Ting-Ting Wu; Richard W Roberts; Ren Sun; H Tom Soh
Journal:  Angew Chem Int Ed Engl       Date:  2011-07-14       Impact factor: 15.336

Review 2.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Nitric oxide and thiol redox regulation of Janus kinase activity.

Authors:  R J Duhé; G A Evans; R A Erwin; R A Kirken; G W Cox; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Complete 1H, 15N and 13C assignments, secondary structure, and topology of recombinant human interleukin-6.

Authors:  G Y Xu; J Hong; T McDonagh; M Stahl; L E Kay; J Seehra; D A Cumming
Journal:  J Biomol NMR       Date:  1996-09       Impact factor: 2.835

6.  The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.

Authors:  Anees Khatib; Balakrishnan Solaimuthu; Michal Ben Yosef; Areej Abu Rmaileh; Mayur Tanna; Gidi Oren; Michal Schlesinger Frisch; Jonathan H Axelrod; Michal Lichtenstein; Yoav D Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

7.  Improved detection of biomarkers in cervico-vaginal mucus (CVM) from postpartum cattle.

Authors:  Mounir Adnane; Paul Kelly; Aspinas Chapwanya; Kieran G Meade; Cliona O'Farrelly
Journal:  BMC Vet Res       Date:  2018-09-29       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.